NEUE (NeueHealth) Research & Development: $0.0 Mil (TTM As of Jun. 2025)


NEUE NeueHealth Inc NEUE
20 GF Score
Price $6.75
GF Value $8.81
! 6 Warning Signs
View Full Analysis

What is NeueHealth Research & Development?

NeueHealth NEUE 20 Research & Development is $0.0 Mil as of Jun. 2025. GuruFocus rates NEUE with a GF Score™ of 20/100 and a GF Value™ of $8.81. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. NeueHealth's Research & Development for the three months ended in Jun. 2025 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 was $0.0 Mil.

NeueHealth  (NYSE:NEUE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

NeueHealth Research & Development Related Terms

NeueHealth Research & Development Historical Data

* Premium members only.

The historical data trend for NeueHealth's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeueHealth Research & Development Chart

NeueHealth Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

NeueHealth Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NEUE
20GF Score
NeueHealth Inc NEUE
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeueHealth Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
NeueHealth (NEUE) has a Research & Development of $0.0 Mil as of Jun. 2025. Research and development expense is the total cost for research and development activities. View historical data on NeueHealth and its competitors.
Is NeueHealth's Research & Development too high?
NeueHealth's current Research & Development is $0.0 Mil. Overall, NeueHealth has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does NeueHealth's Research & Development compare to PFHO and UNH?
NeueHealth's Research & Development of $0.0 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Plans company?
A good Research & Development depends on the Healthcare Plans industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on NeueHealth and its competitors. NeueHealth's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeueHealth stock overvalued right now?
NeueHealth (NEUE) has a current Research & Development of $0.0 Mil. The stock's GF Value™ is $8.81, compared to a current price of $6.75 — trading 23.3% below its estimated fair value. The current Research & Development is $0.0 Mil. NeueHealth's overall GF Score™ is 20/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For NeueHealth (NEUE), the current Research & Development is $0.0 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NeueHealth (NEUE) Overvalued in 2026?

Based on GuruFocus' analysis, NeueHealth stock appears to be undervalued. The current stock price of $6.75 is trading 23.3% below its estimated GF Value™ of $8.81.

Key valuation signals for NEUE:

  • Research & Development: $0.0 Mil
  • GF Value™: $8.81 vs. price of $6.75 (23.3% below fair value)
  • GF Score™: 20/100 with 6 warning signs

No single metric tells the full story. See the NEUE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NeueHealth Business Description

Address 9250 NW 36th Street, Suite 420, Doral, FL, USA, 33178
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.
20GF Score

Get the complete analysis for NEUE

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.75
Price
$8.81
GF Value